Cantel Medical (CMN) Tops Q2 EPS by 9c

Cantel Medical (NYSE: CMN) reported Q2 EPS of $0.43, $0.09 better than the analyst estimate of $0.34. Revenue for the quarter came in at $158.3 million versus the consensus estimate of $154.51 million.

For earnings history and earnings-related data on Cantel Medical (CMN) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• SeaStar Medical (ICU) Misses Q1 EPS by 4c
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance